Since the discovery of erythromycin A (1; Fig. 1 )1} more than 25 biosynthetic representatives of this family of 14-membered macrolide antibiotics have been reported. Most of erythromycins are produced by the genera Saccharopolyspora and Streptomyces but few by Nocardia strains2). Erythromycin E (2; Fig. 1 ) is distinguishable from all the other known macrolide antibiotics and other microbial metabolites by the presence of an ortho-carboxylic acid ester structure. This is supplied by the oxidized form of cladinose which is bonded vicinally to the 14-membered aglycone3).
Formation of 2 was observed whensubmerged cultures
of an idiotrophic mutant of Streptomyces erythreus (ABOTT 2NU153) were incubated with 0.5g erythromycin A/liter. Obviously this strain possesses an early block in erythromycin production and is capable of converting erythromycin A (1) to 2 via an extension of the biosynthetic pathway3). However, the occurrence of erythromycin E ( Fig. 1) has never been reported for non-idiotrophic producer strains of macrolides. Here we report the discovery and range couplings in the HMBC spectrum of 2 confirming the ortho-carboxylic acid ester structure, its unique structural feature.
Coproduced compounds 1 and 8,9-anhydro-pseudoerythromycin A-6,9-hemi-ketal were identified readily via their MS spectra (ESI-CID-MS/MS) and an NMR spectroscopic investigation4^In the crude mixture of erythromycins 1, 2 and 8,9-anhydro-pseudo-erythromycin A-6,9-hemiketal isolated from N. brasiliensis IFM 0466, the portion of erythromycin E (2) was estimated to be 64 % from the relative intensities of the [M+H]+ ions (ESI-MS), which were 1, 2.78 and 0.57 for m\z 734, 748 and 716, respectively. N. brasiliensis IFM 0466 was thus found to be a new producer of erythromycin E rendering this antibiotic available for normal fermentation processes which could supply this unusual structure for semisynthetic modifications. Only one case of the production of erythromycins FEB. 1999 from Nocardia (Nocardia sp. ATCC59045) has been reported5). However, the present Nocardia strain was easily differentiated from strain ATCC59045, which uses nitrogen or carbonsources such as adenine, xanthine and starch. Therefore, we believe that this is also the first isolation of erythromycins from pathogenic N. brasiliensis.
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